中文 | English
Return
Total: 50 , 1/5
Show Home Prev Next End page: GO
Author:(Jifeng FENG)

1.Treatment of primary central nervous system lymphoma

Xiaoyou LI ; Jifeng FENG

Journal of International Oncology 2016;43(1):71-74

2.Study on the clinical efficacy of paclitaxel and capecitabine in treatment ofⅣ period lung adenocarcinoma

Shizheng LUO ; Jifeng FENG

Chinese Journal of Biochemical Pharmaceutics 2014;37(4):131-133

3.Diagnosis and treatment of primary central nervous system lymphoma

Xiaoyou LI ; Jifeng FENG

Journal of International Oncology 2013;40(8):621-624

4.Reversal for acquired resistance to EGFR inhibitors in lung cancer

Chenchen LI ; Jifeng FENG

Journal of International Oncology 2013;40(11):843-846

5.Advances of long non-coding RNA UCA1 in cancers

Dali YAN ; Haixia CAO ; Jifeng FENG

Journal of International Oncology 2017;44(2):108-111

6.Mechanism and strategy of the secondary resistance to EGFR-TKI in patients with lung cancer

Siwen LIU ; Shaorong YU ; Jifeng FENG

Journal of International Oncology 2015;42(1):56-59

7.Research progression on resistance mechanisms of epidermal growth factor receptor tyrosine kinase ;inhibitors in non-small cell lung cancer

Yun LIU ; Jifeng FENG ; Zhaoyue YAN

Journal of International Oncology 2015;(3):206-209

8.Transfection of human endostatin gene in umbilical cord CD34~+ hematopoietic stem cell

Jifeng FENG ; Liangjun ZHU ; Ji HU

Journal of Medical Postgraduates 2004;0(02):-

9.Studies on a selective cyclooxygenase-2 inhibitor celecoxib inhibiting growth of human hepatocellular cancer SMMC-7721 cells lines and inducing apoptosis

Guohao XIA ; Hong CHEN ; Zhi WANG ; Liangxi PAN ; Jifeng FENG

China Oncology 2006;0(09):-

10.Exogenous EGF Effect on Change of Ultra-structure in Sensory Neuron Following Nerve Injury in Rat

Feng ZHANG ; Yudong GU ; Jianguang XU ; Jifeng LI

Fudan University Journal of Medical Sciences 2000;27(6):446-448,452

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 50 , 1/5 Show Home Prev Next End page: GO